Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.39
(1.3%)
AUD 0.39
(1.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -79.3 Million AUD | -673.71% |
| 2023 | -10.25 Million AUD | -43.1% |
| 2022 | -7.16 Million AUD | 66.36% |
| 2021 | -21.29 Million AUD | 12.09% |
| 2020 | -24.22 Million AUD | -414.93% |
| 2019 | -4.7 Million AUD | 72.75% |
| 2018 | -17.26 Million AUD | -201.78% |
| 2017 | -5.72 Million AUD | -56.64% |
| 2016 | -3.65 Million AUD | -179.05% |
| 2015 | -1.3 Million AUD | 47.91% |
| 2014 | -2.51 Million AUD | -688.83% |
| 2013 | 426.71 Thousand AUD | -8.62% |
| 2012 | 466.95 Thousand AUD | 53.8% |
| 2011 | 303.61 Thousand AUD | 1014.22% |
| 2010 | -33.21 Thousand AUD | -243.72% |
| 2009 | -9662.00 AUD | 97.41% |
| 2008 | -373.07 Thousand AUD | 74.77% |
| 2007 | -1.47 Million AUD | -188.91% |
| 2006 | -511.79 Thousand AUD | 69.49% |
| 2005 | -1.67 Million AUD | -28.35% |
| 2004 | -1.3 Million AUD | -48.86% |
| 2003 | -878 Thousand AUD | 70.38% |
| 2002 | -2.96 Million AUD | 49.12% |
| 2001 | -5.82 Million AUD | -32.71% |
| 2000 | -4.39 Million AUD | -576.43% |
| 1999 | -649 Thousand AUD | 84.47% |
| 1998 | -4.18 Million AUD | -321.37% |
| 1997 | -992 Thousand AUD | 65.77% |
| 1996 | -2.89 Million AUD | -229.69% |
| 1995 | -879 Thousand AUD | -131.37% |
| 1994 | 2.8 Million AUD | -34.21% |
| 1993 | 4.25 Million AUD | -24.12% |
| 1992 | 5.61 Million AUD | 11.92% |
| 1991 | 5.01 Million AUD | -7.15% |
| 1990 | 5.4 Million AUD | 5.04% |
| 1989 | 5.14 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -79.3 Million AUD | -673.71% |
| 2024 Q2 | -18.31 Million AUD | 0.0% |
| 2024 Q4 | -79.3 Million AUD | 0.0% |
| 2023 Q2 | -8.68 Million AUD | 0.0% |
| 2023 Q4 | -10.25 Million AUD | 0.0% |
| 2023 FY | -10.25 Million AUD | -43.1% |
| 2022 FY | -7.16 Million AUD | 66.36% |
| 2022 Q4 | -7.16 Million AUD | 0.0% |
| 2022 Q2 | -16.65 Million AUD | 0.0% |
| 2021 Q2 | -18.9 Million AUD | 0.0% |
| 2021 FY | -21.29 Million AUD | 12.09% |
| 2021 Q4 | -21.29 Million AUD | 0.0% |
| 2020 Q2 | -26.72 Million AUD | 0.0% |
| 2020 Q4 | -24.22 Million AUD | 0.0% |
| 2020 FY | -24.22 Million AUD | -414.93% |
| 2019 FY | -4.7 Million AUD | 72.75% |
| 2019 Q2 | -13.53 Million AUD | 0.0% |
| 2019 Q4 | -4.7 Million AUD | 0.0% |
| 2018 Q4 | -17.26 Million AUD | 0.0% |
| 2018 FY | -17.26 Million AUD | -201.78% |
| 2018 Q2 | -2.24 Million AUD | 0.0% |
| 2017 Q4 | -5.72 Million AUD | 0.0% |
| 2017 FY | -5.72 Million AUD | -56.64% |
| 2017 Q2 | -2.37 Million AUD | 0.0% |
| 2016 Q2 | 146.83 Thousand AUD | 0.0% |
| 2016 Q4 | -3.65 Million AUD | 0.0% |
| 2016 FY | -3.65 Million AUD | -179.05% |
| 2015 FY | -1.3 Million AUD | 47.91% |
| 2015 Q4 | -1.3 Million AUD | 0.0% |
| 2014 Q4 | -2.51 Million AUD | 0.0% |
| 2014 FY | -2.51 Million AUD | -688.83% |
| 2013 Q4 | 426.71 Thousand AUD | 0.0% |
| 2013 FY | 426.71 Thousand AUD | -8.62% |
| 2012 FY | 466.95 Thousand AUD | 53.8% |
| 2012 Q4 | 466.95 Thousand AUD | 0.0% |
| 2011 FY | 303.61 Thousand AUD | 1014.22% |
| 2011 Q4 | 50.65 Thousand AUD | 0.0% |
| 2010 Q4 | -33.21 Thousand AUD | 0.0% |
| 2010 FY | -33.21 Thousand AUD | -243.72% |
| 2009 FY | -9662.00 AUD | 97.41% |
| 2009 Q4 | -9662.00 AUD | 0.0% |
| 2008 FY | -373.07 Thousand AUD | 74.77% |
| 2008 Q4 | -373.07 Thousand AUD | 0.0% |
| 2007 FY | -1.47 Million AUD | -188.91% |
| 2007 Q4 | -1.47 Million AUD | 0.0% |
| 2006 Q4 | -220.55 Thousand AUD | 0.0% |
| 2006 FY | -511.79 Thousand AUD | 69.49% |
| 2005 FY | -1.67 Million AUD | -28.35% |
| 2005 Q4 | -1.67 Million AUD | 0.0% |
| 2004 FY | -1.3 Million AUD | -48.86% |
| 2004 Q4 | -1.3 Million AUD | 0.0% |
| 2003 Q4 | -878.01 Thousand AUD | 0.0% |
| 2003 FY | -878 Thousand AUD | 70.38% |
| 2002 FY | -2.96 Million AUD | 49.12% |
| 2002 Q4 | -2.96 Million AUD | 0.0% |
| 2001 FY | -5.82 Million AUD | -32.71% |
| 2001 Q4 | -5.82 Million AUD | 0.0% |
| 2000 FY | -4.39 Million AUD | -576.43% |
| 2000 Q4 | -4.39 Million AUD | 0.0% |
| 1999 FY | -649 Thousand AUD | 84.47% |
| 1999 Q4 | -649 Thousand AUD | 0.0% |
| 1998 FY | -4.18 Million AUD | -321.37% |
| 1997 Q4 | -3.07 Million AUD | 0.0% |
| 1997 FY | -992 Thousand AUD | 65.77% |
| 1996 FY | -2.89 Million AUD | -229.69% |
| 1995 FY | -879 Thousand AUD | -131.37% |
| 1994 FY | 2.8 Million AUD | -34.21% |
| 1993 FY | 4.25 Million AUD | -24.12% |
| 1992 FY | 5.61 Million AUD | 11.92% |
| 1991 FY | 5.01 Million AUD | -7.15% |
| 1990 FY | 5.4 Million AUD | 5.04% |
| 1989 FY | 5.14 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -319.647% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -7975.304% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 1665.087% |
| Biome Australia Limited | -1.56 Million AUD | -4974.723% |
| Patrys Limited | -2.24 Million AUD | -3439.497% |
| Orthocell Limited | -19.92 Million AUD | -298.038% |
| Imugene Limited | -91.56 Million AUD | 13.382% |
| Noxopharm Limited | -2.31 Million AUD | -3318.561% |
| PYC Therapeutics Limited | -65.76 Million AUD | -20.599% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -2497.711% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -680.385% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -1154.112% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -1178.047% |
| CSL Limited | 15.76 Billion AUD | 100.503% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -523.766% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -11077.117% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 56.66% |
| Starpharma Holdings Limited | -19.83 Million AUD | -299.9% |
| Nanollose Limited | -96.22 Thousand AUD | -82319.465% |
| Memphasys Limited | 4.13 Million AUD | 2017.799% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -1216.303% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -1500.845% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -4249.009% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -6304.034% |
| Race Oncology Limited | -17.18 Million AUD | -361.393% |
| Nyrada Inc. | -4.76 Million AUD | -1562.862% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 25.034% |
| Dimerix Limited | -21.99 Million AUD | -260.626% |
| PharmAust Limited | -9.71 Million AUD | -716.422% |
| Immutep Limited | -122.18 Million AUD | 35.094% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 41.901% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -535.49% |
| BTC Health Limited | -2.02 Million AUD | -3821.961% |
| Acrux Limited | -1.45 Million AUD | -5339.515% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -363.953% |
| Biotron Limited | -386.06 Thousand AUD | -20442.529% |
| Tissue Repair Ltd | -16.44 Million AUD | -382.379% |
| AdAlta Limited | -845.17 Thousand AUD | -9283.656% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -326.961% |
| Hexima Limited | -2.22 Million AUD | -3462.467% |
| AnteoTech Limited | -5 Million AUD | -1485.679% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -351.089% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -2235.247% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -1388.168% |
| Actinogen Medical Limited | -9.13 Million AUD | -768.496% |
| Immuron Limited | -11.48 Million AUD | -590.608% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -398.396% |